Advertisement
DRIO vs IRIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRIO is a Hold and IRIX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DRIO’s FA Score shows that 1 FA rating(s) are green whileIRIX’s FA Score has 1 green FA rating(s).
- DRIO’s FA Score: 1 green, 4 red.
- IRIX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DRIO’s TA Score shows that 5 TA indicator(s) are bullish while IRIX’s TA Score has 3 bullish TA indicator(s).
- DRIO’s TA Score: 5 bullish, 4 bearish.
- IRIX’s TA Score: 3 bullish, 5 bearish.
Price Growth
DRIO (@Services to the Health Industry) experienced а -1.25% price change this week, while IRIX (@Medical/Nursing Services) price change was -11.67% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.09%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +25.13%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.
Reported Earning Dates
DRIO is expected to report earnings on Nov 16, 2026.
IRIX is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Services to the Health Industry (+1.09% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Medical/Nursing Services (-0.94% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| DRIO | IRIX | DRIO / IRIX | |
| Capitalization | 73.4M | 13.2M | 556% |
| EBITDA | -34.02M | -1.15M | 2,953% |
| Gain YTD | -34.183 | -33.675 | 102% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 21.2M | 52.6M | 40% |
| Total Cash | 20M | 4.6M | 435% |
| Total Debt | 31.8M | 4.28M | 744% |
DRIO | IRIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 75 | 85 | |
P/E GROWTH RATING 1..100 | 100 | 2 | |
SEASONALITY SCORE 1..100 | 10 | 5 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DRIO's Valuation (23) in the Medical Specialties industry is significantly better than the same rating for IRIX (95). This means that DRIO’s stock grew significantly faster than IRIX’s over the last 12 months.
DRIO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IRIX (100). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
DRIO's SMR Rating (99) in the Medical Specialties industry is in the same range as IRIX (100). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
DRIO's Price Growth Rating (75) in the Medical Specialties industry is in the same range as IRIX (85). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
IRIX's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for DRIO (100). This means that IRIX’s stock grew significantly faster than DRIO’s over the last 12 months.
| DRIO | IRIX | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 86% |
| Stochastic ODDS (%) | 3 days ago 83% | 3 days ago 77% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 87% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 88% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| TrendMonth ODDS (%) | 3 days ago 89% | 3 days ago 82% |
| Advances ODDS (%) | 3 days ago 77% | 6 days ago 75% |
| Declines ODDS (%) | 6 days ago 88% | 3 days ago 80% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 87% |
| Aroon ODDS (%) | 3 days ago 59% | 3 days ago 83% |
Advertisement
DRIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, DRIO has been loosely correlated with MNDR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DRIO jumps, then MNDR could also see price increases.
| Ticker / NAME | Correlation To DRIO | 1D Price Change % | ||
|---|---|---|---|---|
| DRIO | 100% | +4.46% | ||
| MNDR - DRIO | 58% Loosely correlated | -4.02% | ||
| TWST - DRIO | 34% Loosely correlated | +6.79% | ||
| VCYT - DRIO | 28% Poorly correlated | +1.24% | ||
| XWEL - DRIO | 28% Poorly correlated | +11.37% | ||
| BNGO - DRIO | 28% Poorly correlated | -0.83% | ||
More | ||||
IRIX and
Correlation & Price change
A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.
| Ticker / NAME | Correlation To IRIX | 1D Price Change % | ||
|---|---|---|---|---|
| IRIX | 100% | -1.16% | ||
| NTRA - IRIX | 30% Poorly correlated | +2.21% | ||
| NEO - IRIX | 27% Poorly correlated | +2.72% | ||
| IQV - IRIX | 27% Poorly correlated | +1.47% | ||
| MDXH - IRIX | 26% Poorly correlated | +3.21% | ||
| DRIO - IRIX | 26% Poorly correlated | +4.46% | ||
More | ||||